Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-05-22Clinical Trial Update: A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]
This is an update for a Phase I/II clinical study of LBL-024 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
Monopar Therapeutics provides an Expanded Access Program for MNPR-101-PCTA-177Lu in patients with solid tumors, with access currently availa…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function [Phase 1]
Phase 1 pharmacokinetics study of larotinib in subjects with impaired hepatic function, exploring PK in esophageal cancer and solid tumors (…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating AZD1390 in combination with stereotactic body radiotherapy (SBRT) for adults with metastatic solid tumors.…
-
CLINICAL_TRIALS other · 2025-05-14Clinical Trial Update: RAPA-201 Therapy of Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating RAPA-201 for solid tumors, including small cell and non-small cell lung cancer and several head and neck…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update announces CTS3497 for MTAP-deficient malignancies including solid tumors and lymphomas, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers [Phase 2]
A Phase 2 neoadjuvant trial evaluating pembrolizumab before surgery in mismatch repair–deficient locally advanced solid cancers has complete…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors [Phase 1]
DS-1103a combination therapy is being studied in a Phase 1 trial for participants with advanced solid tumors and breast cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Study of SGN1 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating SGN1 in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update announcing a Phase 1/2 study of AP402 in HER2-positive locally advanced or advanced solid tumors; recruitment is ong…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy [Phase 1, Phase 2]
Genmab's GEN1053 antibody study in malignant solid tumors (Phase 1/2) was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation [Phase 1]
Phase 1 clinical trial update of HMBD-001, an anti-HER3 antibody, evaluating its use with or without chemotherapy in solid tumors with NRG1 …
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma [Phase 1]
Phase 1 study of PCLX-001 in relapsed/refractory advanced solid tumors and B-cell non-Hodgkin lymphoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Expression (MATCH - Subprotocol Z1H) [Phase 2]
Phase 2 MATCH subprotocol study evaluating copanlisib as a targeted treatment for cancers with PTEN expression. The trial is currently activ…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update evaluating the combination of veliparib and irinotecan hydrochloride in patients with metastatic or unresectable solid …
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial update of a JAB-3312–based combination therapy in adults with advanced solid tumors has completed (status: completed), inclu…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating tovorafenib in pediatric and young adult participants with relapsed or progressive low-grade glioma and …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy
An ongoing QUANTACT clinical trial evaluating pangenomic quantitative alterations in cancer therapy is currently enrolling by invitation for…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) [Phase 2]
Phase 2 MATCH subprotocol U update on defactinib (VS-6063) for cancers with NF2 genetic changes, with results posted and the trial listed as…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for SYNC-T immunotherapy in patients with advanced or metastatic solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers [Phase 1]
Aplitabart (IGM-8444) Phase 1a/1b study in solid tumors and various hematologic cancers was terminated.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of Sacituzumab Govitecan in Japanese participants with advanced solid tumors is ongoing, including metastatic triple-negativ…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) [Phase 2]
Phase 2 NCI MATCH subprotocol V is evaluating sunitinib for cancers with cKIT genetic alterations, including advanced and refractory lymphom…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: GVAX Plus Checkpoint Blockade in Neuroblastoma [Phase 1]
The Phase 1 trial of GVAX plus checkpoint blockade in neuroblastoma was terminated.